|
J B Chemicals & Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
39940.58 Cr.
|
P/BV
|
9.60
|
Book Value (Rs.)
|
259.05
|
|
52 Week High/Low (Rs.)
|
2491/1604
|
FV/ML
|
1/1
|
P/E(X)
|
56.30
|
|
Bookclosure
|
17/07/2026
|
EPS (Rs.)
|
44.19
|
Div Yield (%)
|
0.88
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 4097.81 | 3867.12 | 3449.08 | 3120.91 | 2397.62 |
| Other Operating Revenues | 49.99 | 50.86 | 35.11 | 28.37 | 26.63 |
| Total Operating Revenues | 4147.79 | 3917.99 | 3484.18 | 3149.28 | 2424.24 |
| | | | | | |
| Other Income | 60.15 | 38.32 | 37.27 | 9.94 | 39.23 |
| Total Revenue | 4207.94 | 3956.31 | 3521.45 | 3159.22 | 2463.47 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 912.44 | 820.03 | 816.28 | 783.98 | 602.22 |
| Purchase Of Stock-In Trade | 477.90 | 496.95 | 412.62 | 395.22 | 258.16 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -94.07 | -0.43 | -46.85 | -11.00 | -17.45 |
| Employee Benefit Expenses | 772.70 | 687.61 | 601.41 | 543.45 | 439.24 |
| Finance Costs | 5.57 | 11.73 | 44.33 | 36.05 | 5.12 |
| Depreciation And Amortisation Expenses | 182.50 | 171.04 | 138.32 | 114.41 | 72.66 |
| Other Expenses | 971.39 | 881.99 | 803.83 | 741.88 | 598.61 |
| Total Expenses | 3228.42 | 3068.92 | 2769.94 | 2603.99 | 1958.57 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 979.51 | 887.39 | 751.51 | 555.23 | 504.90 |
| | | | | | |
| Exceptional Items | -27.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 952.34 | 887.39 | 751.51 | 555.23 | 504.90 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 234.73 | 202.42 | 150.62 | 89.31 | 128.15 |
| Deferred Tax | 10.58 | 27.39 | 47.86 | 55.92 | -9.29 |
| Tax For Earlier Years | -2.45 | -2.01 | 0.39 | 0.00 | 0.00 |
| Total Tax Expenses | 242.86 | 227.81 | 198.88 | 145.23 | 118.86 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 709.47 | 659.58 | 552.63 | 410.01 | 386.04 |
| | | | | | |
| Profit/Loss From Continuing Operations | 709.47 | 659.58 | 552.63 | 410.01 | 386.04 |
| | | | | | |
| Profit/Loss For The Period | 709.47 | 659.58 | 552.63 | 410.01 | 386.04 |
| | | | | | |
| Minority Interest | 0.00 | 0.00 | 0.00 | -0.17 | -0.68 |
| Consolidated Profit/Loss After MI And Associates | 709.47 | 659.58 | 552.63 | 409.84 | 385.36 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 45.16 | 42.45 | 35.66 | 53.00 | 49.86 |
| Diluted EPS (Rs.) | 44.45 | 41.56 | 34.85 | 52.34 | 49.86 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 313.29 | 237.04 | 156.99 | 127.59 | 127.52 |
